Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms

This publication has 82 references indexed in Scilit:

• TH-17 cells in the circle of immunity and autoimmunity
  Nature Immunology, 2007
• Expression of peroxisome proliferator-activated receptor-γ in macrophage suppresses experimentally induced colitis
  American Journal of Physiology-Gastrointestinal and Liver Physiology, 2007
• Peroxisome proliferator–activated receptor (PPAR)α expression in T cells mediates gender differences in development of T cell–mediated autoimmunity
  The Journal of Experimental Medicine, 2007
• Parallel SUMOylation-Dependent Pathways Mediate Gene- and Signal-Specific Transrepression by LXRs and PPARγ
  Molecular Cell, 2007
• Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor γ activity
  The Journal of Experimental Medicine, 2006
• PPARγ, a Lipid‐Activated Transcription Factor as a Regulator of Dendritic Cell Function
  Annals of the New York Academy of Sciences, 2006
• PPAR as a new therapeutic target in inflammatory bowel diseases
  Gut, 2006
• Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation
  European Journal of Pharmacology, 2006
• Interleukin-17 is a potent immuno-modulator and regulator of normal human intestinal epithelial cell growth
  Biochemical and Biophysical Research Communications, 2005
• A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
  Nature, 2005